BEUDAMED
    11 results · 27ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    VAN-TEC MEATAL DILATOR

    FDA 510(k)
    FDA Class 2 ·Gastroenterology, Urology

    KMEDIC

    FDA UDI
    TELEFLEX INCORPORATED·24026704282979·RETRACTOR MEYERDING SMALL 17 MILLIMETER X 55 M...

    ALP VasQcare Take Home System

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    ENCOR 7 GAUGE

    FDA 510(k)
    FDA Class 2 ·Gastroenterology, Urology

    ACUSNARE POLYPECTOMY SNARE

    FDA Adverse Event
    Malfunction ·WILSON-COOK MEDICAL INC·Product code KNS·May 10, 2022

    EDWARDS SAPIEN TRANSCATHETER HEART VALVE

    FDA Adverse Event
    Injury ·EDWARDS LIFESCIENCES·Product code NPT·June 5, 2014

    GORE EXCLUDER AAA ENDOPROSTHESIS

    FDA Adverse Event
    Injury ·W.L. GORE & ASSOCIATES·Product code MIH·November 26, 2012

    RENU (UNKNOWN TYPE)

    FDA Adverse Event
    Injury ·BAUSCH & LOMB·Product code LPN·September 29, 2010

    ACUSNARE POLYPECTOMY SNARE SOFT

    FDA Adverse Event
    Malfunction ·WILSON-COOK MEDICAL INC·Product code KNS·July 13, 2023

    ACUSNARE POLYPECTOMY SNARE

    FDA Adverse Event
    Malfunction ·WILSON-COOK MEDICAL INC·Product code KNS·May 4, 2022

    Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

    FDA Enforcement
    Class II ·Terminated·St Jude Medical Inc.·October 25, 2017